Percheron Therapeutics LimitedASX: PER

First approval for ATL1102 Phase IIb DMD clinical trial

Feb 14, 2023 at 3:06 AM UTC · Issued by Percheron Therapeutics Limited

Percheron Therapeutics Limited has released a press release.

View Attachment